James Budge Sells 781 Shares of Hinge Health (NYSE:HNGE) Stock

Posted by Francis Steltz on May 21st, 2026

Hinge Health Inc. (NYSE:HNGE – Get Free Report) CFO James Budge sold 781 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $55.34, for a total value of $43,220.54. Following the sale, the chief financial officer directly owned 451,293 shares of the company’s stock, valued at $24,974,554.62. The trade was a 0.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Budge also recently made the following trade(s):

On Monday, May 11th, James Budge sold 5,906 shares of Hinge Health stock. The stock was sold at an average price of $54.82, for a total value of $323,766.92.
On Monday, March 23rd, James Budge sold 11,006 shares of Hinge Health stock. The stock was sold at an average price of $42.26, for a total value of $465,113.56.

Hinge Health Trading Up 0.7%

Hinge Health stock traded up $0.37 during trading hours on Thursday, reaching $55.11. 1,101,431 shares of the company were exchanged, compared to its average volume of 1,259,108. The firm has a market cap of $4.26 billion and a price-to-earnings ratio of -4.47. The stock has a 50-day moving average of $44.66 and a 200 day moving average of $44.32. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $62.18.

Hinge Health (NYSE:HNGE – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. The firm had revenue of $182.31 million during the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The firm’s revenue for the quarter was up 47.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.30 EPS. As a group, research analysts forecast that Hinge Health Inc. will post 1.21 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HNGE. Wall Street Zen upgraded Hinge Health from a “hold” rating to a “buy” rating in a report on Sunday, May 10th. Zacks Research upgraded Hinge Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Piper Sandler reiterated an “overweight” rating and set a $95.00 price target on shares of Hinge Health in a report on Wednesday, May 6th. Needham & Company LLC upped their price target on Hinge Health from $59.00 to $63.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Barclays upped their price target on Hinge Health from $52.00 to $62.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $67.40.

Get Our Latest Research Report on Hinge Health

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Wells Fargo & Company MN lifted its position in Hinge Health by 160.0% in the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after purchasing an additional 336 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in Hinge Health in the fourth quarter worth $26,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Hinge Health in the third quarter worth $37,000. CENTRAL TRUST Co bought a new position in Hinge Health in the first quarter worth $37,000. Finally, First Horizon Corp lifted its position in Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after purchasing an additional 531 shares during the period.

About Hinge Health

(Get Free Report)

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.